Geneticure is a personalized medicine company with patented tests that control chronic diseases faster than trial/error, with less cost
Geneticure has raised $1.7M in total funding. The most recent round was Seed. The last funding was announced in June 2022.
Geneticure's investors include M25, Wireframe Ventures, Mayo Clinic Ventures, Fairview Health Services.
Geneticure is headquartered in Minneapolis, United States.
Geneticure is a personalized medicine company with patented tests that control chronic diseases faster than trial/error, with less cost
Geneticure is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Geneticure — Funding & Investors." VCBacked, June 1, 2022, https://www.vcbacked.co/company/geneticure. Accessed August 14, 2026.
VCBacked. (2022). Geneticure — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/geneticure
{{cite web |title=Geneticure — Funding & Investors |url=https://www.vcbacked.co/company/geneticure |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated